Signaling control of the constitutive androstane receptor (CAR)

Abstract

The constitutive androstane receptor (CAR, NR1I3) plays a crucial role in the regulation of drug metabolism, energy homeostasis, and cancer development through modulating the transcription of its numerous target genes. Different from prototypical nuclear receptors, CAR can be activated by either direct ligand binding or ligand-independent (indirect) mechanisms both initiated with nuclear translocation of CAR from the cytoplasm. In comparison to the well-defined ligand-based activation, indirect activation of CAR appears to be exclusively involved in the nuclear translocation through mechanisms yet to be fully understood. Accumulating evidence reveals that without activation, CAR forms a protein complex in the cytoplasm where it can be functionally affected by multiple signaling pathways. In this review, we discuss recent progresses in our understanding of the signaling regulation of CAR nuclear accumulation and activation. We expect that this review will also provide greater insight into the similarity and difference between the mechanisms of direct vs. indirect human CAR activation.

Key words： constitutive androstane receptor; nuclear translocation; phosphorylation; signaling regulation

References

1 BauerD, WolframN, KahlGF, Hirsch-ErnstKI (2004) Transcriptional regulation of CYP2B1 induction in primary rat hepatocyte cultures: repression by epidermal growth factor is mediated via a distal enhancer region. Mol Pharmacol65: 172-180

2 BuckleyDB, KlaassenCD (2009) Induction of mouse UDPglucuronosyltransferase mRNA expression in liver and intestine by activators of aryl-hydrocarbon receptor, constitutive androstane receptor, pregnane X receptor, peroxisome proliferatoractivated receptor alpha, and nuclear factor erythroid 2-related factor 2. Drug Metab Dispos37: 847-856

3 BurkO, ArnoldKA, GeickA, TegudeH, EichelbaumM (2005a) A role for constitutive androstane receptor in the regulation of human intestinal MDR1 expression. Biol Chem386: 503-513

4 BurkO, ArnoldKA, NusslerAK, SchaeffelerE, EfimovaE, AveryBA, AveryMA, FrommMF, EichelbaumM (2005b) Antimalarial artemisinin drugs induce cytochrome P450 and MDR1 expression by activation of xenosensors pregnane X receptor and constitutive androstane receptor. Mol Pharmacol67: 1954-1965

5 CervenyL, SvecovaL, AnzenbacherovaE, VrzalR, StaudF, DvorakZ, UlrichovaJ, AnzenbacherP, PavekP (2007) Valproic acid induces CYP3A4 and MDR1 gene expression by activation of constitutive androstane receptor and pregnane X receptor pathways. Drug Metab Dispos35: 1032-1041

6 ChakrabortyS, KanakasabaiS, BrightJJ (2011) Constitutive androstane receptor agonist CITCO inhibits growth and expansion of brain tumour stem cells. Br J Cancer104: 448-459

7 ChangTK, BandieraSM, ChenJ (2003) Constitutive androstane receptor and pregnane X receptor gene expression in human liver: interindividual variability and correlation with CYP2B6 mRNA levels. Drug Metab Dispos31: 7-10

8 CherringtonNJ, HartleyDP, LiN, JohnsonDR, KlaassenCD (2002) Organ distribution of multidrug resistance proteins 1, 2, and 3 (Mrp1, 2, and 3) mRNA and hepatic induction of Mrp3 by constitutive androstane receptor activators in rats. J Pharmacol Exp Ther300: 97-104

9 CherringtonNJ, SlittAL, MaherJM, ZhangXX, ZhangJ, HuangW, WanYJ, MooreDD, KlaassenCD (2003) Induction of multidrug resistance protein 3 (mrp3) in vivo is independent of constitutive androstane receptor. Drug Metab Dispos31: 1315-1319

10 ColumbanoA, Ledda-ColumbanoGM, PibiriM, CossuC, MenegazziM, MooreDD, HuangW, TianJ, LockerJ (2005) Gadd45beta is induced through a CAR-dependent, TNF-independent pathway in murine liver hyperplasia. Hepatology42: 1118-1126

11 Di FiorePP, SegattoO, TaylorWG, AaronsonSA, PierceJH (1990) EGF receptor and erbB-2 tyrosine kinase domains confer cell specificity for mitogenic signaling. Science248: 79-83

12 DingX, LichtiK, KimI, GonzalezFJ, StaudingerJL (2006) Regulation of constitutive androstane receptor and its target genes by fasting, cAMP, hepatocyte nuclear factor alpha, and the coactivator peroxisome proliferator-activated receptor gamma coactivator-1 alpha. J Biol Chem281: 26540-26551

13 DongB, SahaPK, HuangW, ChenW, Abu-ElheigaLA, WakilSJ, StevensRD, IlkayevaO, NewgardCB, ChanL (2009) Activation of nuclear receptor CAR ameliorates diabetes and fatty liver disease. Proc Natl Acad Sci USA106: 18831-18836

14 DuJ, ChenQ, TakemoriH, XuH (2008) SIK2 can be activated by deprivation of nutrition and it inhibits expression of lipogenic genes in adipocytes. Obesity (Silver Spring)16: 531-538

15 FaucetteSR, SueyoshiT, SmithCM, NegishiM, LecluyseEL, WangH (2006) Differential regulation of hepatic CYP2B6 and CYP3A4 genes by constitutive androstane receptor but not pregnane X receptor. J Pharmacol Exp Ther317: 1200-1209

16 FergusonSS, LeCluyseEL, NegishiM, GoldsteinJA (2002) Regulation of human CYP2C9 by the constitutive androstane receptor: discovery of a new distal binding site. Mol Pharmacol62: 737-746

17 FergusonSS, ChenY, LeCluyseEL, NegishiM, GoldsteinJA (2005) Human CYP2C8 is transcriptionally regulated by the nuclear receptors constitutive androstane receptor, pregnane X receptor, glucocorticoid receptor, and hepatic nuclear factor 4 alpha. Mol Pharmacol68: 747-757

18 FormanBM, TzameliI, ChoiHS, ChenJ, SimhaD, SeolW, EvansRM, MooreDD (1998) Androstane metabolites bind to and deactivate the nuclear receptor CAR-beta. Nature395: 612-615

19 GaoJ, HeJ, ZhaiY, WadaT, XieW (2009) The constitutive androstane receptor is an anti-obesity nuclear receptor that improves insulin sensitivity. J Biol Chem284: 25984-25992

20 Gerbal-ChaloinS, DaujatM, PascussiJM, Pichard-GarciaL, VilaremMJ, MaurelP (2002) Transcriptional regulation of CYP2C9 gene. Role of glucocorticoid receptor and constitutive androstane receptor. J Biol Chem277: 209-217

21 GiguereV (1999) Orphan nuclear receptors: from gene to function. Endocr Rev20: 689-725

22 GoodwinB, HodgsonE, D’CostaDJ, RobertsonGR, LiddleC (2002) Transcriptional regulation of the human CYP3A4 gene by the constitutive androstane receptor. Mol Pharmacol62: 359-365

23 HandschinC, MeyerUA (2003) Induction of drug metabolism: the role of nuclear receptors. Pharmacol Rev55: 649-673

24 HardieDG, RossFA, HawleySA (2012) AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nat Rev Mol Cell Bio13: 251-262

25 HeL, SabetA, DjedjosS, MillerR, SunX, HussainMA, RadovickS, WondisfordFE (2009) Metformin and insulin suppress hepatic gluconeogenesis through phosphorylation of CREB binding protein. Cell137: 635-646

26 HonkakoskiP, ZelkoI, SueyoshiT, NegishiM (1998) The nuclear orphan receptor CAR-retinoid X receptor heterodimer activates the phenobarbital-responsive enhancer module of the CYP2B gene. Mol Cell Biol18: 5652-5658

27 HuangW, ZhangJ, WashingtonM, LiuJ, ParantJM, LozanoG, MooreDD (2005) Xenobiotic stress induces hepatomegaly and liver tumors via the nuclear receptor constitutive androstane receptor. Mol Endocrinol19: 1646-1653

28 InokiK, KimJ, GuanKL (2012) AMPK and mTOR in cellular energy homeostasis and drug targets. Annu Rev Pharmacol52: 381-400

29 JoannardF, RisselM, GilotD, AndersonA, Orfila-LefeuvreL, GuillouzoA, AtfiA, Lagadic-GossmannD (2006) Role for mitogen-activated protein kinases in phenobarbital-induced expression of cytochrome P4502B in primary cultures of rat hepatocytes. Toxicol Lett161: 61-72

30 JohanssonI, Ingelman-SundbergM (2010) Genetic polymorphism and toxicology-withemphasis on cytochromep 450. Toxicol Sci120: 1-13

31 KachayloEM, YarushkinAA, PustylnyakVO (2012) Constitutive androstane receptor activation by 2,4,6-triphenyldioxane-1,3 suppresses the expression of the gluconeogenic genes. Eur J Pharmacol679: 139-143

32 KaminoH, MooreR, NegishiM (2011a) Role of a novel CARinduced gene, TUBA8, in hepatocellular carcinoma cell lines. Cancer Genet204: 382-391

33 KaminoH, YamazakiY, SaitoK, TakizawaD, KakizakiS, MooreR, NegishiM (2011b) Nuclear receptor CAR-regulated expression of the FAM84A gene during the development of mouse liver tumors. Int J Oncol38: 1511-1520

34 KannoY, InoueY, InouyeY (2010) 5-aminoimidazole-4-carboxamide-1-beta-ribofuranoside (AICAR) prevents nuclear translocation of constitutive androstane receptor by AMP-activated protein kinase (AMPK) independent manner. J Toxicol Sci35: 571-576

35 KawamotoT, SueyoshiT, ZelkoI, MooreR, WashburnK, NegishiM (1999) Phenobarbital-responsive nuclear translocation of the receptorCAR in induction of the CYP2B gene. MolCellBiol19: 6318-6322

36 KietzmannT, Hirsch-ErnstKI, KahlGF, JungermannK (1999) Mimicry in primary rat hepatocyte cultures of the in vivo perivenous induction by phenobarbital of cytochrome P-450 2B1 mRNA: role of epidermal growth factor and perivenous oxygen tension. Mol Pharmacol56: 46-53

37 KobayashiK, SueyoshiT, InoueK, MooreR, NegishiM (2003) Cytoplasmic accumulation of the nuclear receptor CAR by a tetratricopeptide repeat protein in HepG2 cells. Mol Pharmacol64: 1069-1075

38 KoikeC, MooreR, NegishiM (2007) Extracellular signal-regulated kinase is an endogenous signal retaining the nuclear constitutive active/androstane receptor (CAR) in the cytoplasm of mouse primary hepatocytes. Mol Pharmacol71: 1217-1221

39 LiH, WangH (2010) Activation of xenobiotic receptors: driving into the nucleus. Expert Opin Drug Metab Toxicol6: 409-426

40 LiL, ChenT, StantonJD, SueyoshiT, NegishiM, WangH (2008) The peripheral benzodiazepine receptor ligand 1-(2-chlorophenyl-methylpropyl)-3-isoquinoline-carboxamide is a novel antagonist of human constitutive androstane receptor. Mol Pharmacol74: 443-453

41 LiH, ChenT, CottrellJ, WangH (2009) Nuclear translocation of adenoviral-enhanced yellow fluorescent protein-tagged-human constitutive androstane receptor (hCAR): a novel tool for screening hCAR activators in human primary hepatocytes. Drug Metab Dispos37: 1098-1106

42 LiL, SinzMW, ZimmermannK, WangH (2012) An insulin-like growth factor 1 receptor inhibitor induces CYP3A4 expression through a pregnane X receptor-independent, noncanonical constitutive androstane receptor-related mechanism. J Pharmacol Exp Ther340: 688-697

43 MaglichJM, StoltzCM, GoodwinB, Hawkins-BrownD, MooreJT, KliewerSA (2002) Nuclear pregnane x receptor and constitutive androstane receptor regulate overlapping but distinct sets of genes involved in xenobiotic detoxification. Mol Pharmacol62: 638-646

44 MaglichJM, ParksDJ, MooreLB, CollinsJL, GoodwinB, BillinAN, StoltzCA, KliewerSA, LambertMH, WillsonTM (2003) Identification of a novel human constitutive androstane receptor (CAR) agonist and its use in the identification of CAR target genes. J Biol Chem278: 17277-17283

45 MaglichJM, WatsonJ, McMillenPJ, GoodwinB, WillsonTM, MooreJT (2004) The nuclear receptor CAR is a regulator of thyroid hormone metabolism during caloric restriction. J Biol Chem279: 19832-19838

46 MakinenJ, FrankC, JyrkkarinneJ, GyntherJ, CarlbergC, HonkakoskiP (2002) Modulation of mouse and human phenobarbital-responsive enhancer module by nuclear receptors. Mol Pharmacol62: 366-378

47 MasuyamaH, HiramatsuY (2012) Treatment with a constitutive androstane receptor ligand ameliorates the signs of preeclampsia in high-fat diet-induced obese pregnant mice. Mol Cell Endocrinol348: 120-127

48 MolnarF, KublbeckJ, JyrkkarinneJ, PrantnerV, HonkakoskiP (2013) An update on the constitutive androstane receptor (CAR). Drug Metabol Drug Interact28: 79-93

49 MooreLB, ParksDJ, JonesSA, BledsoeRK, ConslerTG, StimmelJB, GoodwinB, LiddleC, BlanchardSG, WillsonTM (2000) Orphan nuclear receptors constitutive androstane receptor and pregnane X receptor share xenobiotic and steroid ligands. J Biol Chem275: 15122-15127

50 MutohS, OsabeM, InoueK, MooreR, PedersenL, PereraL, RebollosoY, SueyoshiT, NegishiM (2009) Dephosphorylation of threonine 38 is required for nuclear translocation and activation of human xenobiotic receptor CAR (NR1I3). J Biol Chem284: 34785-34792

51 MutohS, SobhanyM, MooreR, PereraL, PedersenL, SueyoshiT, NegishiM (2013) Phenobarbital indirectly activates the constitutive active androstane receptor (CAR) by inhibition of epidermal growth factor receptor signaling. Sci Signal6: ra31

52 NakajimaY, TakagiH, KakizakiS, HoriguchiN, SatoK, SunagaN, MoriM (2012) Gefitinib and gemcitabine coordinately inhibited the proliferation of cholangiocarcinoma cells. Anticancer Res32: 5251-5262

53 NumazawaS, ShindoS, MaruyamaK, ChibanaF, KawaharaY, AshinoT, TanakaS, YoshidaT (2005) Impaired nuclear translocation ofCAR in hepatic preneoplastic lesions: association with an attenuated CYP2B induction by phenobarbital. FEBS Lett579: 3560-3564

54 OsabeM, NegishiM (2011) Active ERK1/2 protein interacts with the phosphorylated nuclear constitutive active/androstane receptor (CAR; NR1I3), repressing dephosphorylation and sequestering CAR in the cytoplasm. J Biol Chem286: 35763-35769

55 OsabeM, SugataniJ, FukuyamaT, IkushiroS, IkariA, MiwaM (2008) Expression of hepatic UDP-glucuronosyltransferase 1A1 and 1A6 correlated with increased expression of the nuclear constitutive androstane receptor and peroxisome proliferatoractivated receptor alpha in male rats fed a high-fat and highsucrose diet. Drug Metab Dispos36: 294-302

56 OsabeM, SugataniJ, TakemuraA, KurosawaM, YamazakiY, IkariA, MiwaM (2009) Up-regulation of CAR expression through Elk-1 in HepG2 and SW480 cells by serum starvation stress. FEBS Lett583: 885-889

57 PascussiJM, Gerbal-ChaloinS, FabreJM, MaurelP, VilaremMJ (2000) Dexamethasone enhances constitutive androstane receptor expression in human hepatocytes: consequences on cytochrome P450 gene regulation. Mol Pharmacol F58: 1441-1450

58 PascussiJM, Busson-Le ConiatM, MaurelP, VilaremMJ (2003) Transcriptional analysis of the orphan nuclear receptor constitutive androstane receptor (NR1I3) gene promoter: identification of a distal glucocorticoid response element. Mol Endocrinol17: 42-55

59 PlantN (2007) The human cytochrome P450 sub-family: transcriptional regulation, inter-individual variation and interaction networks. Biochim Biophys Acta1770: 478-488

60 QatananiM, MooreDD (2005) CAR, the continuously advancing receptor, in drug metabolism and disease. Curr Drug Metab6: 329-339

61 QatananiM, ZhangJ, MooreDD (2005) Role of the constitutive androstane receptor in xenobiotic-induced thyroid hormone metabolism. Endocrinology146: 995-1002

62 RencurelF, StenhouseA, HawleySA, FriedbergT, HardieDG, SutherlandC, WolfCR (2005) AMP-activated protein kinase mediates phenobarbital induction of CYP2B gene expression in hepatocytes and a newly derived human hepatoma cell line. J Biol Chem280: 4367-4373

63 RencurelF, ForetzM, KaufmannMR, StrokaD, LooserR, LeclercI, da Silva XavierG, RutterGA, ViolletB, MeyerUA (2006) Stimulation of AMP-activated protein kinase is essential for the induction of drug metabolizing enzymes by phenobarbital in human and mouse liver. Mol Pharmacol70: 1925-1934

64 RossJ, PlummerSM, RodeA, ScheerN, BowerCC, VogelO, HendersonCJ, WolfCR, ElcombeCR (2010) Human constitutive androstane receptor (CAR) and pregnane X receptor (PXR) support the hypertrophic but not the hyperplastic response to the murine nongenotoxic hepatocarcinogens phenobarbital and chlordane in vivo. Toxicol Sci116: 452-466

65 RothA, LooserR, KaufmannM, BlattlerSM, RencurelF, HuangW, MooreDD, MeyerUA (2008) Regulatory cross-talk between drug metabolism and lipid homeostasis: constitutive androstane receptor and pregnane X receptor increase Insig-1 expression. Mol Pharmacol73: 1282-1289

66 SaitoK, KobayashiK, MizunoY, FukuchiY, FurihataT, ChibaK (2010) Peroxisome proliferator-activated receptor alpha (PPARalpha) agonists induce constitutive androstane receptor (CAR) and cytochrome P450 2B in rat primary hepatocytes. Drug Metab Pharmacokinet25: 108-111

67 SaitoK, MooreR, NegishiM (2013) p38 mitogen-activated protein kinase regulates nuclear receptor CAR that activates the CYP2B6 gene. Drug Metab Dispos41: 1170-1173

68 ShanL, VincentJ, BrunzelleJS, DussaultI, LinM, IanculescuI, ShermanMA, FormanBM, FernandezEJ (2004) Structure of the murine constitutive androstane receptor complexed to androstenol: a molecular basis for inverse agonism. Mol Cell16: 907-917

69 ShinDM, ZhangH, SabaNF, ChenAY, NannapaneniS, AminAR, MullerS, LewisM, SicaG, KonoS (2013) Chemoprevention of head and neck cancer by simultaneous blocking of epidermal growth factor receptor and cyclooxygenase-2 signaling pathways: preclinical and clinical studies. Clin Cancer Res19: 1244-1256

70 ShindoS, NumazawaS, YoshidaT (2007) A physiological role of AMP-activated protein kinase in phenobarbital-mediated constitutive androstane receptor activation and CYP2B induction. Biochem J401: 735-741

71 SidhuJS, OmiecinskiCJ (1995) cAMP-associated inhibition of phenobarbital-inducible cytochrome P450 gene expression in primary rat hepatocyte cultures. J Biol Chem270: 12762-12773

72 SidhuJS, OmiecinskiCJ (1997) An okadaic acid-sensitive pathway involved in the phenobarbital-mediated induction of CYP2B gene expression in primary rat hepatocyte cultures. J Pharmacol Exp Ther282: 1122-1129

73 StanleyLA, HorsburghBC, RossJ, ScheerN, WolfCR (2006) PXR and CAR: nuclear receptors which play a pivotal role in drug disposition and chemical toxicity. Drug Metab Rev38: 515-597

74 SueyoshiT, MooreR, SugataniJ, MatsumuraY, NegishiM (2008) PPP1R16A, the membrane subunit of protein phosphatase 1beta, signals nuclear translocation of the nuclear receptor constitutive active/androstane receptor. Mol Pharmacol73: 1113-1121

75 SugataniJ, NishitaniS, YamakawaK, YoshinariK, SueyoshiT, NegishiM, MiwaM (2005) Transcriptional regulation ofhumanUGT1A1gene expression: activated glucocorticoid receptor enhances constitutive androstane receptor/pregnane X receptor-mediated UDP-glucuronosyltransferase 1A1 regulation with glucocorticoid receptor-interacting protein 1. Mol Pharmacol67: 845-855

76 TakizawaD, KakizakiS, HoriguchiN, YamazakiY, TojimaH, MoriM (2011) Constitutive active/androstane receptor promotes hepatocarcinogenesis in a mouse model of non-alcoholic steatohepatitis. Carcinogenesis32: 576-583

77 ThaslerWE, DayoubR, MuhlbauerM, HellerbrandC, SingerT, GrabeA, JauchKW, SchlittHJ, WeissTS (2006) Repression of cytochrome P450 activity in human hepatocytes in vitro by a novel hepatotrophic factor, augmenter of liver regeneration. J Pharmacol Exp Ther316: 822-829

78 TolsonAH, WangH (2010) Regulation of drug-metabolizing enzymes by xenobiotic receptors: PXR and CAR. Adv Drug Deliv Rev62: 1238-1249

79 TzameliI, MooreDD (2001) Role reversal: new insights from new ligands for the xenobiotic receptor CAR. Trends Endocrinol Metab12: 7-10

80 TzameliI, PissiosP, SchuetzEG, MooreDD (2000) The xenobiotic compound 1,4-bis[2-(3,5-dichloropyridyloxy)]benzene is an agonist ligand for the nuclear receptor CAR. Mol Cell Biol20: 2951-2958

81 WangH, TompkinsLM (2008) CYP2B6: new insights into a historically overlooked cytochrome P450 isozyme. Curr Drug Metab9: 598-610

82 WangH, FaucetteS, SueyoshiT, MooreR, FergusonS, NegishiM, LeCluyseEL (2003) A novel distal enhancer module regulated by pregnane X receptor/constitutive androstane receptor is essential for the maximal induction of CYP2B6 gene expression. J Biol Chem278: 14146-14152

83 WangD, LiL, YangH, FergusonSS, BaerMR, GartenhausRB, WangH (2013) The constitutive androstane receptor is a novel therapeutic target facilitating cyclophosphamide-based treatment of hematopoietic malignancies. Blood121: 329-338

84 WorthamM, CzerwinskiM, HeL, ParkinsonA, WanYJ (2007) Expression of constitutive androstane receptor, hepatic nuclear factor 4 alpha, and P450 oxidoreductase genes determines interindividual variability in basal expression and activity of a broad scope of xenobiotic metabolism genes in the human liver. Drug Metab Dispos35: 1700-1710

85 XiaJ, KemperB (2007) Subcellular trafficking signals of constitutive androstane receptor: evidence for a nuclear export signal in the DNA-binding domain. Drug Metab Dispos35: 1489-1494

86 XuRX, LambertMH, WiselyBB, WarrenEN, WeinertEE, WaittGM, WilliamsJD, CollinsJL, MooreLB, WillsonTM (2004) A structural basis for constitutive activity in the human CAR/RXRalpha heterodimer. Mol Cell16: 919-928

87 YamamotoY, MooreR, GoldsworthyTL, NegishiM, MaronpotRR (2004) The orphan nuclear receptor constitutive active/androstane receptor is essential for liver tumor promotion by phenobarbital in mice. Cancer Res64: 7197-7200

88 YanagibaY, ItoY, KamijimaM, GonzalezFJ, NakajimaT (2009) Octachlorostyrene induces cytochrome P450, UDP-glucuronosyltransferase, and sulfotransferase via the aryl hydrocarbon receptor and constitutive androstane receptor. Toxicol Sci111: 19-26

89 YangH, GarzelB, HeywardS, MoellerT, ShapiroP, WangH (2013) Metformin represses drug-induced expression of CYP2B6 by modulating the constitutive androstane receptor signaling. Mol Pharmacol85(2): 249-260

90 YoshidaY, KimuraN, OdaH, KakinumaA (1996) Insulin suppresses the induction of CYP2B1 and CYP2B2 gene expression by phenobarbital in adult rat cultured hepatocytes. Biochem Biophys Res Commun229: 182-188

91 YoshinariK, KobayashiK, MooreR, KawamotoT, NegishiM (2003) Identification of the nuclear receptor CAR:HSP90 complex in mouse liver and recruitment of protein phosphatase 2A in response to phenobarbital. FEBS Lett548: 17-20

92 YoshinariK, YodaN, ToriyabeT, YamazoeY (2010) Constitutive androstane receptor transcriptionally activates human CYP1A1 and CYP1A2 genes through a common regulatory element in the 5’-flanking region. Biochem Pharmacol79: 261-269

93 ZelkoI, SueyoshiT, KawamotoT, MooreR, NegishiM (2001) The peptide near the C terminus regulates receptor CAR nuclear translocation induced by xenochemicals in mouse liver. Mol Cell Biol21: 2838-2846

94 ZhangJ, HuangW, ChuaSS, WeiP, MooreDD (2002) Modulation of acetaminophen-induced hepatotoxicity by the xenobiotic receptor CAR. Science298: 422-424